About Accretion Pharmaceuticals Limited IPO
Accretion Pharmaceuticals Limited is a Gujarat-based pharmaceutical manufacturer established in 2012, specializing in tablets, capsules, oral liquids, and external preparations. With an ISO-certified facility in Ahmedabad, the company produces a diverse range of medicines, including antibiotics, cardiovascular drugs, dermatological treatments, and herbal products. Its global presence spans 20+ countries across Africa, Southeast Asia, and the Middle East, supported by a workforce of 83 employees committed to quality and regulatory compliance.
The company’s competitive edge lies in its vertically integrated manufacturing, long-standing client relationships, and expertise in contract development. By focusing on innovation and stringent quality control (ISO 9001:2015, 14001:2015, 22000:2005), Accretion Pharmaceuticals has built trust in both domestic and international markets. Its portfolio caters to therapeutic segments like pain management, pediatrics, and dermatology, positioning it as a reliable partner for healthcare solutions.
Minimum Investment
| Minimum Investment (Retail) | Lots (min) | Shares (QTY) |
| ₹1,21,200 | 1 | 1200 |
Accretion Pharmaceuticals Limited IPO Details
| IPO Date | May 14, 2025 to May 16, 2025 |
| Listing Date | Wed, May 21, 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹96 to ₹101 per share |
| Lot Size | 1,200 Shares |
| Total Issue Size | 29,46,000 shares (aggregating up to ₹29.75 Cr) |
| Fresh Issue | 29,46,000 shares (aggregating up to ₹29.75 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 81,70,000 shares |
| Share Holding Post Issue | 1,11,16,000 shares |
| Market Maker Portion | 1,47,600 shares (Gretex Share Broking Private Limited) |
| IPO Open Date | Wed, May 14, 2025 |
| IPO Close Date | Fri, May 16, 2025 |
| Tentative Allotment | Mon, May 19, 2025 |
| Initiation of Refunds | Tue, May 20, 2025 |
| Credit of Shares to Demat | Tue, May 20, 2025 |
| Tentative Listing Date | Wed, May 21, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 16, 2025 |
Accretion Pharmaceuticals Limited IPO Prospectus
Accretion Pharmaceuticals Limited Financial Snapshot (in Crore)
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 39.99 | 27.05 | 20.58 | 17.74 |
| Revenue | 35.75 | 33.94 | 29.53 | 22.58 |
| Profit After Tax | 5.24 | 3.88 | 0.10 | 0.08 |
| Net Worth | 13.58 | 5.35 | 3.84 | 3.08 |
| Reserves and Surplus | 5.41 | 1.35 | 0.00 | 0.00 |
| Total Borrowing | 13.79 | 13.48 | 8.47 | 7.61 |
Accretion Pharmaceuticals Limited Promoters Holding
Mr. Mayur Popatlal Sojitra, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel and Mr. Hardik Mukundbhai Prajapati
Accretion Pharmaceuticals Limited IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: apl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Accretion Pharmaceuticals Limited IPO Lead Manager(s)
Jawa Capital Services Private Limited
Accretion Pharmaceuticals Limited Contact Details
Accretion Pharmaceuticals Limited
29 Xcelon Ind Park 1,
B/h, Intas Pharmaceuticals,
Vasna Chacharvad, Sanand,
Phone: +91-97148 82929
Email: compliance@accretionpharma.com
Website: https://accretionpharma.com/
